Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial
Introduction Intensive care unit (ICU) patients under mechanical ventilation experience mild-to-severe pain. International guidelines emphasise the importance and benefits of multimodal analgesia to minimise opioid consumption and its side effects. However, no recommendation about drugs or protocol...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/1/e090396.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832592232099610624 |
|---|---|
| author | Thibault Mura Jean-Yves Lefrant Remy Widehem Camille Nicolet Violaine Delannoy Laurie Barthelemi Ian Soulairol Claire Roger |
| author_facet | Thibault Mura Jean-Yves Lefrant Remy Widehem Camille Nicolet Violaine Delannoy Laurie Barthelemi Ian Soulairol Claire Roger |
| author_sort | Thibault Mura |
| collection | DOAJ |
| description | Introduction Intensive care unit (ICU) patients under mechanical ventilation experience mild-to-severe pain. International guidelines emphasise the importance and benefits of multimodal analgesia to minimise opioid consumption and its side effects. However, no recommendation about drugs or protocol has been formulated. The aim of the Opioid-Free Analgesia in Intensive Care Unit study is to assess the feasibility of a standardised multimodal analgesia strategy and its benefits following the impact of remifentanil sparing in ICU patients.Methods and analysis 50 mechanically ventilated adult patients will be recruited in a randomised, placebo-controlled, double-blind, feasibility trial. In the interventional group, patients will receive a standardised multimodal analgesia, initially receiving nefopam and tramadol, implementing with ketamine if patients remain painful, and then implementing with remifentanil with escalating doses in case of insufficient analgesia. In the control group, patients will receive remifentanil, implementing doses gradually to achieve analgesia. The primary outcome will be the daily consumption of remifentanil between the 24th and 48th hour after inclusion. Secondary outcomes will include drug tolerance, mechanical ventilation duration, ICU and hospital length of stay, 28-day and 90-day mortalities and 90-day opioid consumption.Ethics and dissemination The study protocol was accepted by the Nîmes University Hospital’s research committee, the French ethics committee (Institutional Review Board OUEST IV) and the French National Agency for the Safety of Medicines and Health Products (ANSM).Trial registration number ClinicalTrials.gov: NCT05825560 |
| format | Article |
| id | doaj-art-a3050f83aaa1408a9fa10508aae0abfd |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-a3050f83aaa1408a9fa10508aae0abfd2025-01-21T12:35:10ZengBMJ Publishing GroupBMJ Open2044-60552025-01-0115110.1136/bmjopen-2024-090396Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trialThibault Mura0Jean-Yves Lefrant1Remy Widehem2Camille Nicolet3Violaine Delannoy4Laurie Barthelemi5Ian Soulairol6Claire Roger7Department of Pharmacy, University Hospital Centre Nimes, Nimes, Occitanie, FranceDivision of Anesthesia Critical care, Emergency and Pain Medicine, University Hospital Centre Nimes, Nimes, Occitanie, FranceDivision of Anesthesia Critical care, Emergency and Pain Medicine, University Hospital Centre Nimes, Nimes, Occitanie, FranceDivision of Anesthesia Critical care, Emergency and Pain Medicine, University Hospital Centre Nimes, Nimes, Occitanie, FranceDepartment of Pharmacy, Centre Hospitalier Universitaire de Nimes, Nimes, Languedoc-Roussillon, FranceDepartment of Pharmacy, University Hospital Centre Nimes, Nimes, Occitanie, FranceDepartment of Pharmacy, Centre Hospitalier Universitaire de Nimes, Nimes, Languedoc-Roussillon, FranceDivision of Anesthesia Critical care, Emergency and Pain Medicine, University Hospital Centre Nimes, Nimes, Occitanie, FranceIntroduction Intensive care unit (ICU) patients under mechanical ventilation experience mild-to-severe pain. International guidelines emphasise the importance and benefits of multimodal analgesia to minimise opioid consumption and its side effects. However, no recommendation about drugs or protocol has been formulated. The aim of the Opioid-Free Analgesia in Intensive Care Unit study is to assess the feasibility of a standardised multimodal analgesia strategy and its benefits following the impact of remifentanil sparing in ICU patients.Methods and analysis 50 mechanically ventilated adult patients will be recruited in a randomised, placebo-controlled, double-blind, feasibility trial. In the interventional group, patients will receive a standardised multimodal analgesia, initially receiving nefopam and tramadol, implementing with ketamine if patients remain painful, and then implementing with remifentanil with escalating doses in case of insufficient analgesia. In the control group, patients will receive remifentanil, implementing doses gradually to achieve analgesia. The primary outcome will be the daily consumption of remifentanil between the 24th and 48th hour after inclusion. Secondary outcomes will include drug tolerance, mechanical ventilation duration, ICU and hospital length of stay, 28-day and 90-day mortalities and 90-day opioid consumption.Ethics and dissemination The study protocol was accepted by the Nîmes University Hospital’s research committee, the French ethics committee (Institutional Review Board OUEST IV) and the French National Agency for the Safety of Medicines and Health Products (ANSM).Trial registration number ClinicalTrials.gov: NCT05825560https://bmjopen.bmj.com/content/15/1/e090396.full |
| spellingShingle | Thibault Mura Jean-Yves Lefrant Remy Widehem Camille Nicolet Violaine Delannoy Laurie Barthelemi Ian Soulairol Claire Roger Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial BMJ Open |
| title | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial |
| title_full | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial |
| title_fullStr | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial |
| title_full_unstemmed | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial |
| title_short | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial |
| title_sort | effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult icu patients study protocol for a randomised placebo controlled double blind parallel group clinical trial |
| url | https://bmjopen.bmj.com/content/15/1/e090396.full |
| work_keys_str_mv | AT thibaultmura effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT jeanyveslefrant effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT remywidehem effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT camillenicolet effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT violainedelannoy effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT lauriebarthelemi effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT iansoulairol effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial AT claireroger effectofamultimodalanalgesiastrategyonremifentanildailyconsumptioninmechanicallyventilatedadulticupatientsstudyprotocolforarandomisedplacebocontrolleddoubleblindparallelgroupclinicaltrial |